Accessibility Menu
VioQuest Pharmaceuticals logo

VioQuest Pharmaceuticals(OTC) VOQP

Current Price$0.00
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-100%
5 Year-100%
1 Year-100%
1 Month+0%
VioQuest Pharmaceuticals last closing stock price
MetricPriceDate
Last closeUSD 0.002024-09-25
VioQuest Pharmaceuticals stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002023-12-01
1 month+0%USD 0.002023-12-01
3 month+0%USD 0.002023-12-01
Year to date+0%USD 0.002023-12-01
1 year-99.97%USD 0.002022-09-07
3 year-99.97%USD 0.002021-09-03
5 year-99.99%USD 0.012019-09-12
Since inception-100%USD 20.102003-02-19

VioQuest Pharmaceuticals Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.11M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-114.65 (Low)

Price

$0.00

Volume

24

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Feb 26, 2025

VOQP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VioQuest Pharmaceuticals

VioQuest Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and marketing drug therapies for oncology and infectious diseases. The company is advancing several clinical-stage products, including Xyfid, VQD-002, and Lenocta, while also providing specialized synthesis development services.

Products and Services
  • Xyfid for managing and preventing hand-foot syndrome
  • VQD-002, a nucleoside analog in Phase I trials for cancer
  • Lenocta, targeting various solid tumors in Phase IIa studies
Growth Outlook
  • Pipeline includes multiple products in advanced clinical stages
  • Focus on oncology and infectious diseases aligns with market demand
  • Potential for strategic partnerships to enhance development capabilities
Financial Highlights
  • Recent quarterly net income of -$1.14 million, reflecting ongoing R&D investments
  • Cash and cash equivalents of $814,477 as of June 30, 2008
  • Trailing twelve months (TTM) revenue of $0, indicating early-stage development
VioQuest Pharmaceuticals operates in a dynamic sector with a focus on innovative therapies. The company's commitment to developing treatments for significant health challenges positions it well for future growth. With a pipeline of promising products and a strategic approach to partnerships, VioQuest Pharmaceuticals presents an intriguing opportunity for investors interested in the biotechnology field. The financial data indicates a focus on research and development, which is essential for long-term success in the biopharmaceutical industry.
AI Generated • Jul 24, 2026

Industry

Pharmaceuticals

Headquarters

Basking Ridge, NJ 07920, US

VOQP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

1325.43%

Return on Capital

N/A

Return on Assets

-801.83%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.46M

Volume

24

Avg. Volume

0

Financials (TTM)

Gross Profit

$0.00

Operating Income

$8.01M

EBITDA

-$5.85M

Operating Cash Flow

-$6.99M

Capital Expenditure

-$2.85K

Free Cash Flow

-$7.00M

Cash & ST Invst.

$814.48K

Total Debt

$0.00

VioQuest Pharmaceuticals Performance Analysis

VioQuest Pharmaceuticals sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32007-09-30N/A
Q42007-12-31N/A
Q12008-03-31N/A
Q22008-06-30N/A
VioQuest Pharmaceuticals sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32007-09-30-16.7%
Q42007-12-31-0.1%
Q12008-03-310.1%
Q22008-06-3063.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2008YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

3

N/A

Net Income

-$1.13M

+54.3%

EBITDA

-$1.03M

+52.1%

Quarterly Fundamentals

Name
Q2 2008YOY CHG

Total Cash

$814.48K

-71.2%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-8.02%

N/A

Return on Invested Capital

-2.17%

N/A

Free Cash Flow

-$1.55M

-53.9%

Operating Cash Flow

-$1.55M

-53.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RGINRegenicin, Inc.
$0.00+0.00%
QBIOQ BioMed Inc.
$0.00-0.00%
PARDPoniard Pharmaceuticals, Inc.
$0.00+0.00%
SCPSScopus BioPharma Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%
AALAmerican Airlines Group
$14.48+0.07%

Questions About VOQP

What is the current price of VioQuest Pharmaceuticals?

VioQuest Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for VioQuest Pharmaceuticals?

Over the past 52 weeks, VioQuest Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does VioQuest Pharmaceuticals have?

VioQuest Pharmaceuticals total debt is unavailable.

How much cash does VioQuest Pharmaceuticals have on hand?

VioQuest Pharmaceuticals does not have cash on hand data available.

What is VioQuest Pharmaceuticals’s dividend yield?

VioQuest Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.